Research statistics

AICAR research: publications and trials

What has been published on AICAR: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether AICAR works or is safe. For what it is and what the studies found, see the AICAR profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

1,954

Since 1966

Publications in 2026 so far

65

Through November 15, 2026

Human clinical research

2.4%

47 of 1,941 classified

Registered clinical trials

4

ClinicalTrials.gov

Randomized controlled trials

10

Publications reporting an RCT in people

Systematic reviews and meta-analyses

2

Preclinical studies

94.9%

1,188 animal · 647 in vitro · 7 computational

Records that only mention it

613

Not counted above

Status in the library: Research only. 13 publications are not yet classified by study type.

What to keep in mind

  • More than 70% of the indexed publications are animal, cell or computational studies.
  • Some completed trials have neither posted results nor a linked results publication.
  • Not a peptide: it is shown for completeness and left out of every peptide total.

Publications by year

AICAR publications by year and evidence

1966, Other and not yet classified: 1 of 11976, Preclinical (animal, in vitro, computational): 1 of 21976, Other and not yet classified: 1 of 21977, Preclinical (animal, in vitro, computational): 1 of 11981, Preclinical (animal, in vitro, computational): 2 of 21982, Preclinical (animal, in vitro, computational): 2 of 21984, Preclinical (animal, in vitro, computational): 2 of 31984, Reviews and meta-analyses: 1 of 31985, Human clinical research: 1 of 71985, Preclinical (animal, in vitro, computational): 6 of 71986, Preclinical (animal, in vitro, computational): 6 of 71986, Other and not yet classified: 1 of 71987, Preclinical (animal, in vitro, computational): 2 of 31987, Other and not yet classified: 1 of 31988, Preclinical (animal, in vitro, computational): 2 of 21989, Preclinical (animal, in vitro, computational): 4 of 51989, Other and not yet classified: 1 of 51990, Preclinical (animal, in vitro, computational): 5 of 51991, Human clinical research: 1 of 121991, Preclinical (animal, in vitro, computational): 9 of 121991, Other and not yet classified: 2 of 121992, Preclinical (animal, in vitro, computational): 7 of 71993, Human clinical research: 1 of 141993, Preclinical (animal, in vitro, computational): 8 of 141993, Reviews and meta-analyses: 2 of 141993, Other and not yet classified: 3 of 141994, Human clinical research: 3 of 201994, Preclinical (animal, in vitro, computational): 12 of 201994, Reviews and meta-analyses: 2 of 201994, Other and not yet classified: 3 of 201995, Human clinical research: 3 of 181995, Preclinical (animal, in vitro, computational): 13 of 181995, Reviews and meta-analyses: 1 of 181995, Other and not yet classified: 1 of 181996, Preclinical (animal, in vitro, computational): 7 of 71997, Human clinical research: 2 of 151997, Preclinical (animal, in vitro, computational): 9 of 151997, Reviews and meta-analyses: 2 of 151997, Other and not yet classified: 2 of 151998, Preclinical (animal, in vitro, computational): 11 of 121998, Reviews and meta-analyses: 1 of 121999, Preclinical (animal, in vitro, computational): 11 of 151999, Reviews and meta-analyses: 3 of 151999, Other and not yet classified: 1 of 152000, Human clinical research: 1 of 192000, Preclinical (animal, in vitro, computational): 17 of 192000, Reviews and meta-analyses: 1 of 192001, Preclinical (animal, in vitro, computational): 29 of 292002, Preclinical (animal, in vitro, computational): 29 of 302002, Reviews and meta-analyses: 1 of 302003, Human clinical research: 1 of 292003, Preclinical (animal, in vitro, computational): 26 of 292003, Reviews and meta-analyses: 2 of 292004, Human clinical research: 3 of 462004, Preclinical (animal, in vitro, computational): 41 of 462004, Reviews and meta-analyses: 2 of 462005, Preclinical (animal, in vitro, computational): 53 of 542005, Other and not yet classified: 1 of 542006, Human clinical research: 1 of 612006, Preclinical (animal, in vitro, computational): 58 of 612006, Other and not yet classified: 2 of 612007, Human clinical research: 1 of 682007, Preclinical (animal, in vitro, computational): 66 of 682007, Other and not yet classified: 1 of 682008, Human clinical research: 1 of 792008, Preclinical (animal, in vitro, computational): 74 of 792008, Reviews and meta-analyses: 4 of 792009, Human clinical research: 3 of 732009, Preclinical (animal, in vitro, computational): 69 of 732009, Reviews and meta-analyses: 1 of 732010, Human clinical research: 2 of 932010, Preclinical (animal, in vitro, computational): 89 of 932010, Reviews and meta-analyses: 1 of 932010, Other and not yet classified: 1 of 932011, Human clinical research: 1 of 1142011, Preclinical (animal, in vitro, computational): 111 of 1142011, Reviews and meta-analyses: 1 of 1142011, Other and not yet classified: 1 of 1142012, Human clinical research: 3 of 822012, Preclinical (animal, in vitro, computational): 77 of 822012, Reviews and meta-analyses: 1 of 822012, Other and not yet classified: 1 of 822013, Preclinical (animal, in vitro, computational): 92 of 922014, Human clinical research: 2 of 962014, Preclinical (animal, in vitro, computational): 92 of 962014, Reviews and meta-analyses: 2 of 962015, Human clinical research: 2 of 1022015, Preclinical (animal, in vitro, computational): 98 of 1022015, Reviews and meta-analyses: 1 of 1022015, Other and not yet classified: 1 of 1022016, Human clinical research: 2 of 832016, Preclinical (animal, in vitro, computational): 79 of 832016, Reviews and meta-analyses: 2 of 832017, Human clinical research: 1 of 752017, Preclinical (animal, in vitro, computational): 73 of 752017, Reviews and meta-analyses: 1 of 752018, Human clinical research: 2 of 892018, Preclinical (animal, in vitro, computational): 85 of 892018, Reviews and meta-analyses: 1 of 892018, Other and not yet classified: 1 of 892019, Human clinical research: 2 of 702019, Preclinical (animal, in vitro, computational): 65 of 702019, Reviews and meta-analyses: 3 of 702020, Human clinical research: 2 of 702020, Preclinical (animal, in vitro, computational): 68 of 702021, Human clinical research: 1 of 532021, Preclinical (animal, in vitro, computational): 51 of 532021, Reviews and meta-analyses: 1 of 532022, Human clinical research: 1 of 592022, Preclinical (animal, in vitro, computational): 58 of 592023, Human clinical research: 1 of 482023, Preclinical (animal, in vitro, computational): 47 of 482024, Human clinical research: 2 of 562024, Preclinical (animal, in vitro, computational): 54 of 562025, Preclinical (animal, in vitro, computational): 57 of 592025, Reviews and meta-analyses: 2 of 592026 (to date), Human clinical research: 1 of 652026 (to date), Preclinical (animal, in vitro, computational): 64 of 65Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified05010015019661989199920092026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
196600011
197601012
197701001
198102002
198202002
198402103
198516007
198606017
198702013
198802002
198904015
199005005
1991190212
199207007
1993182314
19943122320
19953131118
199607007
1997292215
19980111012
19990113115
20001171019
20010290029
20020291030
20031262029
20043412046
20050530154
20061580261
20071660168
20081744079
20093691073
20102891193
2011111111114
20123771182
20130920092
20142922096
201529811102
20162792083
20171731075
20182851189
20192653070
20202680070
20211511053
20221580059
20231470048
20242540056
20250572059
2026 (to date)1640065

Study types

Animal study1,188
In vitro study647
Review37
Other clinical trial19
Observational human study15
Editorial, letter or other13
Not yet classified13
Randomized controlled trial10
Computational study7
Case report3
Meta-analysis1
Systematic review1

Research areas

From MeSH major topics. A paper can be in several areas.

Metabolic health612
Cardiovascular376
Musculoskeletal356
Oncology262
Endocrinology223
Immune system215
Neurological and mental health200
Gastrointestinal137
Reproductive and sexual health104
Tissue repair78
Obesity and weight management72
Longevity and aging59

Registered clinical trials

1 of 1 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 2 · Terminated: 2
Phase not applicable: 1 · Phase 1 / Phase 2: 2 · Phase 3: 1

TrialStatusPhaseStartedResults
GFM-Acadesine: A Phase I-II Trial of AcadesineNCT01813838 · 5 enrolledTerminatedPhase 1, Phase 22013-06—
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)NCT00872001 · 3,080 enrolledTerminatedPhase 32009-04Posted
Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL PatientsNCT00559624 · 40 enrolledCompletedPhase 1, Phase 22007-12—
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 DiabetesNCT00168519 · 40 enrolledCompletedPhase not applicable2002-10—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

    JAMA · January 1, 1997 · Meta-analysis · cited 115 times

    PMID 9002496 · DOI 10.1001/jama.277.4.325 · Reviews and meta-analyses

  2. AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review.

    Cells · May 4, 2021 · Systematic review · cited 161 times · open access

    PMID 34064363 · DOI 10.3390/cells10051095 · Reviews and meta-analyses

  3. Predictors of contemporary coronary artery bypass grafting outcomes.

    The Journal of thoracic and cardiovascular surgery · August 14, 2014 · Randomized controlled trial · cited 34 times · open access

    PMID 25218533 · DOI 10.1016/j.jtcvs.2014.08.018 · Human clinical research

  4. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.

    JAMA · July 1, 2012 · Randomized controlled trial · cited 48 times

    PMID 22782417 · DOI 10.1001/jama.2012.7633 · Human clinical research

  5. Alternative splice variant PGC-1α-b is strongly induced by exercise in human skeletal muscle.

    American journal of physiology. Endocrinology and metabolism · August 23, 2011 · Randomized controlled trial · cited 71 times

    PMID 21862727 · DOI 10.1152/ajpendo.00119.2011 · Human clinical research

  6. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.

    Journal of the American College of Cardiology · May 11, 2006 · Randomized controlled trial · cited 91 times · open access

    PMID 16814669 · DOI 10.1016/j.jacc.2006.04.044 · Human clinical research

  7. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group.

    The Journal of thoracic and cardiovascular surgery · October 1, 1995 · Randomized controlled trial · cited 41 times · open access

    PMID 7475138 · DOI 10.1016/s0022-5223(05)80179-5 · Human clinical research

  8. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

    Anesthesiology · October 1, 1995 · Randomized controlled trial · cited 38 times

    PMID 7574044 · DOI 10.1097/00000542-199510000-00004 · Human clinical research

  9. Acadesine inhibits neutrophil CD11b up-regulation in vitro and during in vivo cardiopulmonary bypass.

    The Journal of thoracic and cardiovascular surgery · March 1, 1995 · Randomized controlled trial · cited 37 times · open access

    PMID 7877305 · DOI 10.1016/s0022-5223(95)70275-x · Human clinical research

  10. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.

    Cardiovascular drugs and therapy · April 1, 1994 · Randomized controlled trial · cited 6 times

    PMID 7918131 · DOI 10.1007/bf00877327 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.

    Journal of biology · September 24, 2003 · In vitro study · cited 1,665 times · open access

    PMID 14511394 · DOI 10.1186/1475-4924-2-28 · In vitro studies

  2. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

    European journal of biochemistry · April 1, 1995 · Animal study · cited 1,230 times

    PMID 7744080 · DOI 10.1111/j.1432-1033.1995.tb20498.x · Animal studies

  3. AMPK and PPARdelta agonists are exercise mimetics.

    Cell · July 31, 2008 · Animal study · cited 1,219 times · open access

    PMID 18674809 · DOI 10.1016/j.cell.2008.06.051 · Animal studies

  4. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.

    The American journal of physiology · December 1, 1997 · Animal study · cited 1,027 times · open access

    PMID 9435525 · DOI 10.1152/ajpendo.1997.273.6.e1107 · Animal studies

  5. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

    Cancer research · July 1, 2007 · Animal study · cited 923 times · open access

    PMID 17638885 · DOI 10.1158/0008-5472.can-06-4447 · Animal studies

Latest publications

  1. Mechanism by which metformin alleviates neuralgia in the spinal cord of diabetic rats.

    Neuroscience · November 6, 2026 · Animal study · cited 0 times

    PMID 42994557 · DOI 10.1016/j.neuroscience.2026.11.008 · Animal studies

  2. AICAR induces S phase cell cycle arrest in ESCC by targeting the AMPK/mTORC1 and mTORC2/AKT pathway.

    Frontiers in oncology · October 22, 2026 · In vitro study · cited 0 times · open access

    PMID 42990857 · DOI 10.3389/fonc.2026.1975805 · In vitro studies

  3. Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling.

    Cells · October 20, 2026 · Animal study · cited 0 times

    PMID 42929878 · DOI 10.3390/cells15201906 · Animal studies

  4. NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling.

    Journal of molecular medicine (Berlin, Germany) · October 20, 2026 · In vitro study · cited 0 times

    PMID 42897352 · DOI 10.1007/s00109-026-02730-5 · In vitro studies

  5. Quantitative Analysis Reveals IL-17A Widens Nasal Epithelial Tight Junction Gaps via AMPK in Allergic Rhinitis.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · October 19, 2026 · In vitro study · cited 0 times

    PMID 42896827 · DOI 10.1016/j.anai.2026.10.001 · In vitro studies

  6. AMPK activation stabilizes HIF-2α by disrupting VHL binding and promotes erythroid differentiation under anemic stress via the mTOR pathway.

    Frontiers in physiology · October 16, 2026 · In vitro study · cited 0 times · open access

    PMID 42964228 · DOI 10.3389/fphys.2026.1932780 · In vitro studies

  7. Sirt3 deficiency impairs AMPK-Acc1 antilipogenic signaling in female adipocytes.

    Molecular biology reports · October 16, 2026 · Animal study · cited 0 times

    PMID 42886405 · DOI 10.1007/s11033-026-12892-7 · Animal studies

  8. AICAR-induced energy supply and paracrine activity of endothelial cells accelerate chronic diabetic wound healing by promoting angiogenesis and modulating macrophage reprogramming.

    Materials today. Bio · October 9, 2026 · Animal study · cited 0 times · open access

    PMID 42899161 · DOI 10.1016/j.mtbio.2026.103743 · Animal studies

  9. Impaired fatty acid oxidation and mitochondrial injury mediated by the AMPK/PPARα pathway: A key mechanism in high-fat diet-aggravated ulcerative colitis.

    PloS one · October 7, 2026 · Animal study · cited 0 times · open access

    PMID 42842576 · DOI 10.1371/journal.pone.0358354 · Animal studies

  10. [<i>Jiaotaiwan</i> improves lipid metabolism abnormalities in a mouse model of Alzheimer disease by regulating the AMPK signaling pathway].

    Nan fang yi ke da xue xue bao = Journal of Southern Medical University · October 1, 2026 · Animal study · cited 0 times

    PMID 42934111 · DOI 10.12122/j.issn.1673-4254.2026.10.19 · Animal studies

Browse all 1,954 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Acadesine; AICA riboside; AICAR; GP-1-110; Z-riboside

((TITLE_ABS:"Acadesine" OR CHEM:"Acadesine") OR (TITLE_ABS:"AICA riboside" OR CHEM:"AICA riboside") OR (TITLE_ABS:"AICAR" OR CHEM:"AICAR") OR (TITLE_ABS:"GP-1-110" OR CHEM:"GP-1-110" OR TITLE_ABS:"GP1-110" OR CHEM:"GP1-110") OR (TITLE_ABS:"Z-riboside" OR CHEM:"Z-riboside")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). AICAR research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/aicar